Prognostic value of peripheral blood markers in patients with myositis-associated interstitial lung diseases

References

• Selva-O’Callaghan A, Pinal-Fernandez I, Trallero-Araguas E, Milisenda JC, Grau-Junyent JM, Mammen AL. Classification and management of adult inflammatory myopathies. Lancet Neurol 2018;17:816–28.
   PubMed Web of Science ®Google Scholar
• Olazagasti JM, Niewold TB, Reed AM. Immunological biomarkers in dermatomyositis. Curr Rheumatol Rep 2015;17:68.
   PubMed Web of Science ®Google Scholar
• Meyer A, Meyer N, Schaeffer M, Gottenberg JE, Geny B, Sibilia J. Incidence and prevalence of inflammatory myopathies: a systematic review. Rheumatology (Oxford) 2015;54:50–63.
   PubMed Web of Science ®Google Scholar
• Johnson C, Pinal-Fernandez I, Parikh R, Paik J, Albayda J, Mammen AL, et al. Assessment of mortality in autoimmune myositis with and without associated interstitial lung disease. Lung 2016;194:733–7.
   PubMed Web of Science ®Google Scholar
• Fathi M, Dastmalchi M, Rasmussen E, Lundberg IE, Tornling G. Interstitial lung disease, a common manifestation of newly diagnosed polymyositis and dermatomyositis. Ann Rheum Dis 2004;63:297–301.
   PubMed Web of Science ®Google Scholar
• Obert J, Freynet O, Nunes H, Brillet PY, Miyara M, Dhote R, et al. Outcome and prognostic factors in a French cohort of patients with myositis-associated interstitial lung disease. Rheumatol Int 2016;36:1727–35.
   PubMed Web of Science ®Google Scholar
• Yamasaki Y, Yamada H, Ohkubo M, Yamasaki M, Azuma K, Ogawa H, et al. Longterm survival and associated risk factors in patients with adult-onset idiopathic inflammatory myopathies and amyopathic dermatomyositis: experience in a single institute in Japan. J Rheumatol 2011;38:1636–43.
   PubMed Web of Science ®Google Scholar
• Kamiya H, Panlaqui OM, Izumi S, Sozu T. Systematic review and meta-analysis of prognostic factors for idiopathic inflammatory myopathy-associated interstitial lung disease. BMJ Open 2018;8:e023998.
   PubMed Web of Science ®Google Scholar
• Yang W, Wang X, Zhang W, Ying H, Xu Y, Zhang J, et al. Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio are 2 new inflammatory markers associated with pulmonary involvement and disease activity in patients with dermatomyositis. Clin Chim Acta 2017;465:11–16.
   PubMed Web of Science ®Google Scholar
• Ha YJ, Hur J, Go DJ, Kang EH, Park JK, Lee EY, et al. Baseline peripheral blood neutrophil-to-lymphocyte ratio could predict survival in patients with adult polymyositis and dermatomyositis: a retrospective observational study. PLoS One 2018;13:e0190411.
   PubMed Web of Science ®Google Scholar
• Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975;292:344–7.
   PubMed Web of Science ®Google Scholar
• Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975;292:403–7.
   PubMed Web of Science ®Google Scholar
• Gerami P, Schope JM, McDonald L, Walling HW, Sontheimer RD. A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis sine myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies. J Am Acad Dermatol 2006;54:597–613.
   PubMed Web of Science ®Google Scholar
• Ikezoe J, Johkoh T, Kohno N, Takeuchi N, Ichikado K, Nakamura H. High-resolution CT findings of lung disease in patients with polymyositis and dermatomyositis. J Thorac Imaging 1996;11:250–9.
   PubMed Web of Science ®Google Scholar
• Li L, Wang Q, Yang F, Wu C, Chen S, Wen X, et al. Anti-MDA5 antibody as a potential diagnostic and prognostic biomarker in patients with dermatomyositis. Oncotarget 2017;8:26552–64.
   PubMedGoogle Scholar
• Angkananard T, Anothaisintawee T, McEvoy M, Attia J, Thakkinstian A. Neutrophil lymphocyte ratio and cardiovascular disease risk: a systematic review and meta-analysis. Biomed Res Int 2018;2018:2703518.
   PubMed Web of Science ®Google Scholar
• Woziwodzka K, Dziewierz A, Pawica M, Panek A, Krzanowski M, Golasa P, et al. Neutrophil-to-lymphocyte ratio predicts long-term all-cause mortality in patients with chronic kidney disease stage 5. Folia Med Cracov 2019;59:55–70.
   PubMedGoogle Scholar
• Toraman A, Nese N, Ozyurt BC, Kursat S. Association between neutrophil-lymphocyte & platelet lymphocyte ratios with prognosis & mortality in rapidly progressive glomerulonephritis. Indian J Med Res 2019;150:399–406.
   PubMed Web of Science ®Google Scholar
• Halper-Stromberg E, Yun JH, Parker MM, Singer RT, Gaggar A, Silverman EK, et al. Systemic markers of adaptive and innate immunity are associated with chronic obstructive pulmonary disease severity and spirometric disease progression. Am J Respir Cell Mol Biol 2018;58:500–9.
   PubMed Web of Science ®Google Scholar
• Sakurai K, Chubachi S, Irie H, Tsutsumi A, Kameyama N, Kamatani T, et al. Clinical utility of blood neutrophil-lymphocyte ratio in Japanese COPD patients. BMC Pulm Med 2018;18:65.
   PubMed Web of Science ®Google Scholar
• Hao X, Li D, Wu D, Zhang N. The relationship between hematological indices and Autoimmune Rheumatic Diseases (ARDs), a meta-analysis. Sci Rep 2017;7:10833.
   PubMed Web of Science ®Google Scholar
• Yang Z, Zhang Z, Lin F, Ren Y, Liu D, Zhong R, et al. Comparisons of neutrophil-, monocyte-, eosinophil-, and basophil-lymphocyte ratios among various systemic autoimmune rheumatic diseases. APMIS 2017;125:863–71.
   PubMed Web of Science ®Google Scholar
• Torres-Ruiz J, Carrillo-Vazquez DA, Padilla-Ortiz DM, Vazquez-Rodriguez R, Nunez-Alvarez C, Juarez-Vega G, et al. TLR expression in peripheral monocyte subsets of patients with idiopathic inflammatory myopathies: association with clinical and immunological features. J Transl Med 2020;18:125.
   PubMed Web of Science ®Google Scholar
• Feng M, Guo H, Zhang C, Wang Y, Liang Z, Zhao X, et al. Absolute reduction of regulatory T cells and regulatory effect of short-term and low-dose IL-2 in polymyositis or dermatomyositis. Int Immunopharmacol 2019;77:105912.
   PubMed Web of Science ®Google Scholar
• Feng F, Tian Y, Liu S, Zheng G, Liu Z, Xu G, et al. Combination of PLR, MLR, MWR, and tumor size could significantly increase the prognostic value for gastrointestinal stromal tumors. Medicine (Baltimore) 2016;95:e3248.
   PubMed Web of Science ®Google Scholar
• Mazza MG, Tringali AGM, Rossetti A, Botti RE, Clerici M. Cross-sectional study of neutrophil-lymphocyte, platelet-lymphocyte and monocyte-lymphocyte ratios in mood disorders. Gen Hosp Psychiatry 2019;58:7–12.
   PubMed Web of Science ®Google Scholar
• Huang Y, Deng W, Zheng S, Feng F, Huang Z, Huang Q, et al. Relationship between monocytes to lymphocytes ratio and axial spondyloarthritis. Int Immunopharmacol 2018;57:43–6.
   PubMed Web of Science ®Google Scholar
• He Y, Tang J, Wu B, Yang B, Ou Q, Lin J. Correlation between albumin to fibrinogen ratio, C-reactive protein to albumin ratio and Th17 cells in patients with rheumatoid arthritis. Clin Chim Acta 2020;500:149–54.
   PubMed Web of Science ®Google Scholar
• Shimojima Y, Ishii W, Matsuda M, Ikeda S. Phenotypes of peripheral blood lymphocytes and cytokine expression in polymyositis and dermatomyositis before treatment and after clinical remission. Clin Med Insights Arthritis Musculoskelet Disord 2012;5:77–87.
   PubMedGoogle Scholar
• Gono T, Kaneko H, Kawaguchi Y, Hanaoka M, Kataoka S, Kuwana M, et al. Cytokine profiles in polymyositis and dermatomyositis complicated by rapidly progressive or chronic interstitial lung disease. Rheumatology (Oxford) 2014;53:2196–203.
   PubMed Web of Science ®Google Scholar
• Li L, Chen J, Chen S, Liu C, Zhang F, Li Y. Serum C1q concentration positively correlates with erythrocyte sedimentation rate in polymyositis/dermatomyositis. Ann Clin Lab Sci 2019;49:237–41.
   PubMed Web of Science ®Google Scholar
• Peng YF, Pan Y, Pan GG, Wei YS, Luo B. Platelet to lymphocyte ratio in polymyositis as a marker of disease activity. Clin Lab 2016;62:915–9.
   PubMed Web of Science ®Google Scholar
• Fujiki Y, Kotani T, Isoda K, Ishida T, Shoda T, Yoshida S, et al. Evaluation of clinical prognostic factors for interstitial pneumonia in anti-MDA5 antibody-positive dermatomyositis patients. Mod Rheumatol 2018;28:133–40.
   PubMed Web of Science ®Google Scholar
• Zhang SH, Peng Y, Xie QB, Yin G, Yan B. [Risk factors of respiratory failure in the dermatomyositis patients with interstitial lung disease], in Chinese. Sichuan Da Xue Xue Bao Yi Xue Ban 2018;49:188–94.
   PubMedGoogle Scholar